default author photo

Angie Goldsberry

Reata Pharmaceuticals

Dallas, TX

United States

SCHOLARLY PAPERS

1

DOWNLOADS

195

TOTAL CITATIONS

3

Scholarly Papers (1)

1.

Safety and Efficacy of Omaveloxolone in Friedreich's Ataxia (MOXIe Study): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

Number of pages: 144 Posted: 15 Jul 2020
University of Pennsylvania - Division of Neurology, Reata Pharmaceuticals, University of Melbourne - Victorian Clinical Genetics Services, University of Florida - Department of Neurology, Ohio State University (OSU) - Department of Neurology, Medical University of Innsbruck - Department of Neurology, Medical University of Innsbruck - Department of Neurology, Fondazione IRCCS Istituto Neurologico ‘Carlo Besta’ - Unit of Medical Genetics and Neurogenetics, University of Iowa - Department of Neurology, Government of the United Kingdom - University College London Hospital, Emory University - Department of Neurology, University of South Florida - Ataxia Research Center, University of California, Los Angeles (UCLA) - Department of Neurology, Reata Pharmaceuticals, Reata Pharmaceuticals and Reata Pharmaceuticals
Downloads 195 (389,821)
Citation 3

Abstract:

Loading...

Friedreich's ataxia; Omaveloxolone